ContraFect Corp’s Post

View organization page for ContraFect Corp, graphic

3,440 followers

On Friday, we submitted the IND application to the FDA for CF-370! We are doing what few others are...developing NEW mechanisms to treat severe, life-threatening infections. The lytic action is unprecedented in the fight against Gram-negative pathogens. Thank you to all the players (too many to name) at ContraFect who made this happen. We can make the difference for patients infected by the most dangerous bacterial pathogens in the world.

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics